Aldevron News: Corporate News

Aldevron capacity, capability growth key to gene, cell and protein therapeutics research

0319-GEN-logoAldevron is "Driven by a Passion to Enable Science," as featured in the April Genetic Engineering & Biotechnology News. This article spans our new production facility in Fargo, North Dakota, and the expansion of our Freiburg, Germany, antibody facility, to our expanding CRISPR options, the publication discusses our ongoing push to help researchers in their work.

One particular highlight is the discussion of our new CRISPR options, including GMP level SpyFiTM Cas9 Nuclease and the availability of in-stock GMP level prepacked CRISPR nucleases.

Read More

Aldevron Names Lance Monilaws as Director of Industrial Project Management

Lance Monilaws of Aldevron has been promoted as its Director of Industrial Project Management. In his position, Monilaws will direct large capital projects with emphasis in facility expansion, renovation and campus planning. He will also manage various operational initiatives and strategies, including but not limited to construction and industrial technology.

Read More

Aldevron Hires Dr. Victoria Sowemimo as Director of Quality Assurance

Dr. Victoria Sowemimo has joined Aldevron as its new Director of Quality Assurance. In her position, Sowemimo will lead the company’s cGMP Quality Assurance functions supporting through all phases of clinical and commercial product release, management of Aldevron’s quality systems and regulatory training to assure compliance to all phase appropriate requirements pertaining to Good Manufacturing Practices.

Read More